Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

0.0%

-86.6% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

1 of 0 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment reporting

Analytics

Phase 1/2
2(66.7%)
N/A
1(33.3%)
3Total
Phase 1/2(2)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT07863180Phase 1/2Recruiting

Tributyrin for Progressive Supranuclear Palsy (PSP): Virtual Trial

Role: collaborator

NCT07154511Phase 1/2Recruiting

Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments

Role: collaborator

NCT05778695Not ApplicableTerminated

Brain Small Chain Fatty Acid Metabolism in Parkinson Disease: Ketones

Role: collaborator

All 3 trials loaded